Try Free

Day 45: VP Sara Duterte Impeachment (Part 4) Atty. Gular vs Atty. Robles Mainit na SAGUTAN

Pinas News November 21, 2026 1h 10m 9,546 words 1 views
▶ Watch original video

About this transcript: This is a full AI-generated transcript of Day 45: VP Sara Duterte Impeachment (Part 4) Atty. Gular vs Atty. Robles Mainit na SAGUTAN from Pinas News, published November 21, 2026. The transcript contains 9,546 words with timestamps and was generated using Whisper AI.

"...factor ng banana chips for export ang Kali 88. We are now really confused, Your Honor, and it is at this point that we will respectfully insist a back-read and production of the transcript of stenographic notes because the direction of Attorney Ray's cross-examination is diametrically opposed to"

[0:00] ...factor ng banana chips for export ang Kali 88. [0:05] We are now really confused, Your Honor, and it is at this point that we will respectfully insist a back-read and production of the transcript of stenographic notes because the direction of Attorney Ray's cross-examination is diametrically opposed to his previous stipulations, Your Honor. [0:22] This is the only other point, Your Honor. [0:24] We have to be able to be clarified of the extent of the stipulations. [0:27] This has nothing to do with the certificate of product registration. [0:31] This is all fairness, Your Honor. [0:33] We ask a back-read of the transcript of stenographic notes and the exact wording that were uttered from the mouth of Attorney Ray. [0:41] And they were issued. [0:42] So now you're questioning what? [0:44] No, Your Honor, I'm just trying to clarify from the witness. [0:46] Kindly call your next witness, Attorney Justin. [0:52] Will you still be the one handling it? [0:53] Yes, Your Honor. [0:54] Okay, kindly call your witness. [0:55] For our next witness, Your Honor, may we call to the witness stand, Ms. Pilar Marilyn M. Pagayunan, MBA. [1:07] Of FDA. [1:08] Of FDA. [1:09] Food and Drug Administration, Your Honor. [1:10] Kindly situate the witness to the witness stand. [1:15] The clerk is directed to administer the oath to the said witness. [1:23] On the part of the prosecution, who will be standing in your behalf? [1:33] It will be Attorney Robles, Your Honor. [1:35] Good afternoon, Your Honor. [1:40] Good afternoon, Attorney Robles. [1:41] Good afternoon, Attorney Robles. [1:42] Good afternoon, Attorney Robles. [1:43] Ma'am, kindly raise your right hand. [1:47] You, Pilar Marilyn Pagayunan, do swear that the evidence you shall give in the case now pending between the Philippines [1:56] and Vice President Cyrus Zimmerman Duterte shall be the truth, the whole truth, and nothing but the truth. [2:01] So help you God. [2:02] Yes, I swear. [2:04] Kindly sit down, ma'am. [2:07] Ma'am, ano po ang tawag sa inyo? Pilar or Marilyn or...? [2:12] Your Honor, I would prefer Marilyn. [2:15] Marilyn? [2:16] Yes, po. [2:17] Okay. [2:18] Ma'am Marilyn, naunawaan niyo po ba ang inyong pinanumpaan kaugnay sa pagbibigay niyo na inyong testimonya sa hapong ito? [2:23] Opo. [2:25] Your Honor, based on the subpoena that I received, I will have to testify. [2:31] Doon po sa product registration documents that were submitted by the Cali 8 Food Corporation to FDA. [2:39] That is correct, ma'am. [2:40] Yeah. [2:41] That is correct, ma'am. [2:42] And the certificate of product registration issued under the company, the Cali 8 Food Corporation. [2:46] Based on the subpoena, ma'am, let the lawyers take care of that. [2:51] Attorney Justin, offer? [2:53] Yes, Your Honor. [2:54] Thank you, Your Honor. [2:56] We are offering the testimony of Madam Pilar Marilyn M. Pagayunan, MBA, sorry, for the following purposes, Your Honor. [3:08] Number one, that she is a director for the Center for Food Regulation and Research under the Food and Drug Administration or the FDA. [3:17] Number two, by authority of the Director General of the FDA, she issued and signed the Certificate of Product Registration of Cali 88 Foods Corporation for sweetened banana chips with FDA registration number FR4-00009768567 on August 17, 2022 and valid until August 16, 2027. [3:45] Number three, Cali 88 Foods Corporation was engaged in lawful legitimate export business of sweetened banana chips and had the requisite license to operate and the certificate of product registration issued, rather, by the FDA. [4:03] Number four, to disprove the material allegations under Article 2 of the Articles of Impeachment and the Supposed Forensic Report of Attorney Alexander B. Cabrera to identify documents and, of course, to testify on matters related to the foregoing. [4:18] Attorney Ray, comment? [4:20] Attorney Ray, your Honours, for the purpose of expediting the proceedings, we are willing to stipulate on the first and second purposes. [4:29] And for the third and fourth purposes, we are going to cross-examine the witness in that regard. [4:36] Also to abbreviate the proceedings, Attorney Ray, are you willing to stipulate as to the you've been given a copy of the documents the witness will be testifying to? [4:44] Attorney Ray, are you willing to stipulate as to the authenticity, due execution, existence, and the fact that these are on record? [4:55] Attorney Ray, your Honours, for the witness will be able to identify them. [5:00] Attorney Ray, your Honours, for the truth of the contents of the law. [5:03] Attorney Ray, your Honours, again, briefly, not as long as the prior witness, just please allow me to manifest the marking so I could continuously conduct my direct examination. [5:13] Attorney Ray, of course. Given that manifestation and stipulation, you may do so, counsel, for purposes of marking and for purposes of spreading into the records the documents that the witness would be able to identify whether you present it to her directly in the course of your direct or not. [5:32] At least it will be part of the records. [5:33] Attorney Ray, your Honours, given the stipulation of the prosecution, we would just like to request the marking of the following documents that were produced directly. [5:42] Attorney Ray, your Honours, by the Food and Drug Administration. [5:47] Number one, FDA letter of denial dated February 24, 2022. [5:51] We request that this be marked as Defense Exhibit D-2-43-CALI-88. [5:55] Number two, Intertech test report for CALI-88 Food Corporation. [6:02] Next would be the order of payment. [6:03] We request that this be marked as Defense Exhibit D-2-45-CALI-88. [6:15] Next is CALI-88. [6:16] Next would be the order of payment dated May 4, 2022. [6:34] We request that this be marked as Defense Exhibit D-2-46-CALI-88. [6:39] Next would be certificate of product registration in close parenthesis low-risk food product with FDA registration number FR-4-0000-9004-164 in favor of CALI-88 Foods Corporation issued on June 15, 2022, valid until June 15, 2027. [7:03] And next, we request that that be marked as Defense Exhibit D-2-47-CALI-88. [7:15] Next document would be the license to operate number 3-0000-912-7981 for FR ending with 8567. [7:27] We request that it be marked as Defense Exhibit D-2-48-CALI-88. [7:32] The second set of documents provided by the witness covered by FR-8567. [7:38] We also request that the following documents be marked. [7:43] CALI-88 Food Corporation's letter dated July 2, 2022. [7:47] We request that it be marked as Defense Exhibit D-2-49-CALI-88. [7:52] Order of payment dated July 14, 2022. [7:56] We request that this be marked as Defense Exhibit D-2-50-CALI-88. [8:01] Next is certificate of product registration in close parenthesis raw material with FDA registration number FR-4-0000-976-8567 in favor of CALI-88 Foods Corporation issued on August 17, 2022, valid until August 17, 2027. [8:22] We request that this be marked as Defense Exhibit D-2-51-CALI-88. [8:29] Next would be photos of a generic box for CALI-88. [8:33] Which is a brand name. [8:34] We request that this be marked as Defense Exhibit D-2-52-CALI-88. [8:40] And license to operate number 3-0000-912-7981. [8:48] Which is the same as the one previously marked, but it is with the set of documents for FR-8567. [8:57] We request that the same license to operate number, license to operate rather, be marked as Defense Exhibit D-2-53-CALI-88. [9:07] That would be all, Your Honor. [9:08] So ordered. [9:09] Thank you, Your Honor. [9:10] May I proceed to my direct examination, Your Honor? [9:13] You may proceed with your direct counsel. [9:15] Ma'am, for the record po, magandang hapon. [9:18] Can you please state your name and your position? [9:20] I am Pilar Marilyn M. Pagayunan, the Director for the Center for Food Regulation and Research of the Food and Drug Administration. [9:30] And what is your duties and responsibilities? [9:33] Since I am the Director for the Center for Food and Drug Administration, the responsibility of the Center for Food Regulation is to be in charge of the regulation of food products processed within the mandate of FDA. [9:51] And this would include the registration processing of applications and evaluation of the product registration. [10:03] Thank you, Ma'am. [10:04] In accordance to the applicable rules and regulations of the FDA issuances. [10:11] Thank you, Ma'am. [10:12] Thank you, Ma'am. [10:13] Thank you, Ma'am. [10:14] Thank you, Ma'am. [10:15] Thank you, Ma'am. [10:16] Thank you, Ma'am. [10:17] Thank you, Ma'am. [10:18] Thank you, Ma'am. [10:20] Ma'am, how long have you been with the Food and Drug Administration? [10:23] My first government employment is since 1990 that was in National Food Authority, the Food Development Center, and I was transferred to the nutrition service of the Department of Health. [10:40] And because of the reorganization of the Department of Health, I was transferred also to the BFAD then, before FDA, in December 2000. [10:56] And until now, so I was in the Food and Drug Administration. [11:01] Okay. [11:02] Maraming salamat po, Ma'am. [11:03] At para maintindahan po namin lahat, Ma'am, ano po itong FDA, Ma'am? [11:08] Just a general description. [11:10] FDA is a food and agency, the Food and Drug Administration under the Department of Health, which says the mission or which says the jurisdiction among health products to ensure the safety, efficacy, and quality of health products that would include drugs, medical device, cosmetics, and then preferred processed food. [11:39] Okay, Ma'am. [11:40] Earlier, Ma'am, sinipulate po ng ating prosecution na ikaw po ay director for ng FDA, particularly Center for Food and Regulation Research. [11:50] Ano po itong Center for Food and Regulation Research po? [11:55] Yung Center for Food and Research is one of the Center under the Food and Drug Administration, which has the responsibility to regulate processed food. [12:06] At isa dun po sa trabaho namin. [12:07] At isa dun po sa trabaho namin is to evaluate and process application for product registration in accordance to the applicable rules and regulations and FDA issuances po. [12:22] Thank you po. [12:23] Thank you po. [12:25] Now, as Director for of the Center of Food and Regulation Research, what are your duties and responsibilities? [12:31] I would like to be specific specific po dito sa product registration. [12:38] So, yung process po kasi ng product registration, as of now, it's an electronic process which the applicant has to apply online. [12:48] And then the process would entail, there will be online application of the applicant, then it will have to be pre assessed in accordance to the completeness of the requirements that was submitted by the applicant company. [13:04] And then it will be, after the pre-assessment, then there will be payment. Then payment, it will be posted by the cashier, by the other department. And then it will be evaluated and then checked. And then that's the time that I will be the final approving authority. So that's my involvement. [13:25] Ma'am, kinunfirm po kanina na may mga documents po kayong isinumute dito sa impeachment court. Kaugnay na po sa sapina na in-issue para sa inyo. [13:38] Unahin ko na po, pero bago tayo pumunta sa mga document to, if you know ma'am, what set of FDA guidelines applies to manufacturers, traders, and distributors such as exporters of processed food? Ano po yung current guidelines natin dyan? [13:58] Kasi sir, I was asked to testify with regards to the product registration, right? So we have an issue once, the AO 2014-0029 that would cover the licensing of the establishment and the registration of pre-packaged food products. [14:19] Okay. Ma'am, one of the documents that you submitted is in relation to, you confirm ma'am that there were two sets of documents. Tama po ba? [14:29] Yung isa is FR ending 4164 and the other one would be FR ending 8567. You confirm. [14:39] Punta po natin yung unang set of documents po, ma'am. Para lang ano. In the first set of documents, one of the documents you brought is an FDA letter of denial dated February 24, 2022. [14:54] Do you have that document with you now, ma'am? [14:56] Yes, Your Honor. [14:57] Can you please explain to us what that letter is, ma'am? [15:00] Okay. Okay. So this is the letter that when the application was received and evaluated by the FDA, which is submitted by Jessica Tequillo as the representative of the company that, I think, applied for the product registration of the sweetened banana chips. [15:25] Yes, it's for local distribution. So when it was evaluated, there was deficiencies that were found. And so if you apply for the product registration, it can be, the result can be denied and approved. [15:44] So if there's a denial, the company will comply with the grants for the reason why. And then there's an opportunity for the company to reapply within six months from the date the initial, the denial was sent to the email of the representative of the company. [16:06] Okay. Thank you, ma'am. In that letter of denial from the FDA, who is the company involved there, ma'am? Just for transparency and for the record. [16:15] Based on the letter of denial, the company is Cali 88 Foods Corporation because it was addressed to that company. [16:25] Okay. And for transparency, ma'am, can you please read and explain the grounds stated in that letter kung bakit po na-deny ang application ng Cali 88 Foods Corporation? [16:36] Okay. So it was denied because the documents, there are inconsistency, Your Honor. In the process of the application, the online application, the company should, there's a provision there that you have to specify the list of ingredients. [16:55] Okay. And in that particular information, we have to validate in the label that was submitted as part also of the requirements for the product registration so that in the particular item, there is inconsistent declaration because we have to be consistent what you upload and what you put in the online application. [17:23] It should be the same. [17:27] Okay. Thank you, ma'am. Now, I've followed the chronology of the documents that you submitted. And the next document is actually that you submitted before this impeachment court. It's actually a Cali 88 Foods Corporation's letter with attached photos of products and packaging dated April 30, 2022. [17:45] May we also request the tech to please flash this document. Can we scroll down, please, to the contents of the letter first? [17:54] So it is… [17:55] Ma'am, yeah. Sorry. [17:56] Sorry. [17:57] It's okay, ma'am. [17:58] Okay. Ma'am, my question is, what is the relation of that letter from Cali 88 Foods Corporation to the earlier letter of the FDA letter of denial dated February 24, 2022, if any, ma'am? [18:15] The relation of this letter to the letter of denial, the company is informing the Food and Drug Administration, Your Honor, that they are now applying for the reapplication and they are addressing the deficiencies that were identified in the letter of denial and they will be filing a reapplication. [18:42] Okay. Now, in that application, ma'am, there's actually an attachment. If you look at the document, the last pages of… [18:49] It states in the letter that there are attachments. Can we please scroll down to the attachments as well? We asked that it be shown. [18:57] Now, these appear to be packagings, ma'am, of Cali's banana chips. [19:07] Tapos may, I would assume, dried banana chips. Ano po ito, ma'am? How is this related to the letter upon which these are attached to? [19:20] So, this is the packaging that was submitted in the initial application. And it was evaluated in accordance to the regulations on labeling based on the FDA Philippines regulation on food labeling. [19:40] So, this was evaluated. So, that's why there was a denial as a result of that evaluation in the initial because that was the one submitted initially. [19:52] Okay, ma'am. So, based on the… [19:55] Okay, ma'am. Para lang po, klaro, ma'am. Let's look at the screen right now. And it appears to be a plastic packaging with the label, banana… [20:05] Can we request the… [20:08] Banana… [20:09] Banana goodness… [20:10] Banana goodness… [20:11] In every bite. [20:12] In every bite. [20:13] And there is nutritional facts below. [20:16] Now, you said earlier that this is in response to the earlier denial. How is the submission of these photos of packagings a response to the earlier denial? [20:27] Para po sa amin na hindi pamilyar sa mga requirements sa FDA. [20:30] Sir… [20:31] Sir… [20:32] Sir, indeed to… [20:33] These are the… [20:34] The… [20:35] Documents… [20:36] As part of the documents that was submitted in the earlier application. [20:40] Now, it was denied because the FDA evaluator finds the non-compliant to the labeling regulations of FDA. [20:49] So, as present… [20:51] As declared in the denial letter. [20:55] So, non-declaration of the complete nutrition facts. [21:00] And then, there is a… [21:02] There is a… [21:04] There is a… [21:05] The claims initially regarding the banana because this is considered as nutrient content claims or health claim. [21:15] Because Cardava is the highest content of nutrients because it is the deepest roots among other banana plants. [21:21] Okay. [21:22] Ma'am, can we go back to the letter? [21:24] Just the last paragraph of the letter dated April 30, 2022. [21:30] Can we zoom in on that? [21:31] Please check on the last paragraph. [21:37] And we… [21:39] Do you have that document, ma'am? [21:40] Can you counter… [21:41] Left, please. [21:42] It states there… [21:43] Based on the aforementioned grounds of denial, we already reflected and amended the deficiencies made in our last application for registration attached in this letter as Annex A is the former and the revised label of our product in accordance with the labeling guidelines provided by Administrative Order No. 2014-0030. [22:09] Again, it stated we already rectified and amended. [22:13] Ma'am, sa mga dokumento na sinumitin nyo, ano po yung mga na-rectify at na-amend na mga packaging? [22:19] As far as I remember, it was deleted. [22:22] Deleted po yung claims. [22:24] And then, there's a complete notification information declaration and it is being supported by the certificate of analysis that was, I think, submitted… [22:38] Okay. [22:39] …that was marked earlier because it's the product that has been applied is for the local distribution. [22:45] Okay. [22:46] Now, you referred to an analysis. [22:50] What relation does the… [22:52] I am showing you now the Intertech Test Report for Cali 88 Food Corporation with attached photos of products and packaging dated March 29, 2022. [23:04] Ano po yan na document, ma'am? [23:08] Sa amin po na hindi alam kung ano po yung relevance ng document na yan. [23:11] Okay. [23:12] So, because sa prepackaged food product, you honor, kailangan po natin maglagay ng nutrition information. [23:18] So, you cannot just put… [23:19] Hindi pwede pong manghula na ito ang protein content, ito yung total fat, ito yung carbohydrates, ito. [23:28] So, it has to be justified through a certificate of analysis. [23:34] So, this is the proximate… [23:36] This is what you call proximate analysis to support the declaration of the nutrition facts na sinasabi pong nire-rectify na ng applicant company as a response to the letter of denial that was issued a while ago, right? [23:54] I think there are photos attached to that. [23:57] I'm just… [23:58] Apo. [23:59] Can we just focus on those photos too? [24:03] Hmm. [24:04] This one. [24:11] Baba pa. [24:12] Or meron… [24:13] Yan. [24:14] Can we zoom out just… [24:15] So, ito, ma'am. [24:16] These are… [24:17] Based on that Intertech test report, there are boxes and labeling, ma'am. [24:23] How is that relevant to the rectification that you referred to earlier, ma'am? [24:28] I think, sir, your owner, you have to flash this one, the packaging… [24:34] Because that's the secondary packaging. [24:37] Ah, what packaging… [24:38] Primary. [24:39] Is that the primary, ma'am? [24:40] Yeah. [24:41] That's the primary. [24:42] Sorry, ma'am. [24:43] Hindi ako familiar sa packaging. [24:44] And thank you for helping. [24:45] And thank you for helping. [24:47] Can we zoom on that banana chips and the packaging itself, ma'am? [24:51] Can we rotate if it's possible? [24:53] Okay. [24:58] Now, ma'am, same question. [24:59] What is the relevance of this… [25:01] It states there… [25:04] Kales banana chips. [25:06] And then, it's a front and meron din pong back. [25:09] Ano pong relevance nito sa sinabi niyo kanina na compliance of the letter of denial? [25:14] Yeah. [25:15] So, this shows the labeling that was attached to the reapplication. [25:20] Your Honor, yung letter. [25:21] Okay. [25:22] Diba? [25:23] May ano… [25:24] So, it means na tinanggal na yung ano… [25:26] Yung claim that Cardaba has… [25:28] And then, it's already compliant when it comes to nutrition facts [25:33] because the declaration of the nutrition facts is already complete. [25:38] And it was supported by the laboratory test result. [25:43] Ma'am, balik pa rin po tayo sa Intertech Test Report. [25:46] Sino po yung kumuha ng test report na yan? [25:50] Base sa dokumento po. [25:51] It was part of the submission. [25:54] Sino po yung kumuha po? [25:56] Sinong korporasyon? [25:57] Kumuha? [25:58] Oo. [25:59] Or nagpa-test report? [26:00] Bakit may test report na ganyan? [26:01] That's part of your submission. [26:03] And who submitted that, ma'am? [26:04] The Cali. [26:05] Cali Food Corporation. [26:06] Okay. [26:07] Because that's the company that submitted the application for… [26:10] Okay. [26:11] Ma'am, para makakuha po ng test report na ganyan, [26:13] ano po yung mga ginagamit ng kumpanya para sa mga out mga results na nakikita natin? [26:20] Sir, kasi this is not being done by the FDA, right? [26:24] Yeah. [26:25] So, it was only submitted as part of the documentary requirements [26:30] relative to your reapplication. [26:33] Your Honor. [26:34] Yeah. [26:35] I will just ask the question directly, ma'am. [26:37] Kailangan po ba nilang i-test yung banana chips mismo sa report? [26:40] Attorney Justin, with their permission, with their indulgence… [26:43] Yes, what is it, Attorney Ray? [26:44] Your Honor, to abbreviate the proceedings, I don't think there's a need to go into all of these details. [26:49] It was already stipulated that the Cali 88 was duly issued a certificate of registration. [26:58] And to go through the denial, the packaging, and everything would be an utter waste of the time of the Honorable Court. [27:05] Maybe you can go to the… [27:06] Do you concede, Attorney Ray, that there is indeed a product… [27:11] Yes. [27:12] …as shown in the picture earlier? [27:14] …and a CPR was issued. [27:15] No, no. [27:16] Your Honor, for us… [27:17] No, no. [27:18] That's not my question, Attorney Ray. [27:19] Do you concede that there is such a product as shown in the picture earlier and in the attachment submitted? [27:31] Yes. [27:32] The pictures were submitted and a sample of the product was given and analyzed. [27:37] Yes. [27:38] Wala ba kayong dala, Attorney Justin, na banana chip dyan? [27:41] Unfortunately, Your Honor, in due time, hindi pa po namin natikmat. [27:46] But may we just… [27:47] We will present the proper evidence through the proper witness. [27:51] Yes. [27:52] We were laying the basis. [27:53] Baka lang may dala kasi kayo. [27:54] Let's clarify, Your Honor, maybe we could expedite the proceedings. [27:57] The extent of the prosecution stipulation. [28:00] Are they now stipulating that Cali 88 Foods Corporation has indeed a product, a banana chip product, Your Honor? [28:09] No, Your Honor, we are stipulating that Cali 88 applied for a certificate of product registration. [28:19] They submitted the appropriate requirements, including a sample of the product, and that the Food and Drug Administration through the Center for Food Registration and Research issued the certificate of product registration after processing the application. [28:37] Apologies, Your Honor. [28:38] Because that's given the extent of the stipulation… [28:40] That's the entire extent of the testimony of the witness, Your Honor. [28:43] Is that the entire extent of the testimony of the witness? [28:47] I will have to continue, Your Honor. [28:49] I hope you understand. [28:50] Unless they stipulate that there is indeed a product… [28:53] Your Honor, you already stipulated that they submitted samples of the product, and that's the only extent… [29:01] I mean, unless they can print the product here, Your Honor. [29:04] So, that is the… [29:07] Even the witness cannot say that there's a product. [29:10] Only that samples were submitted to them, Your Honor. [29:13] Your Honor, that's a conclusion. [29:14] Hold on, hold on. [29:15] I think we're splitting hairs here, Counsel. [29:18] Whether or not X amount of the product were produced or sold is different. [29:25] Yes. [29:26] But what all that the witness will testify to is there is indeed a product. [29:32] There is a product that was sought to be registered… [29:36] And it was duly registered. [29:37] And it was duly registered. [29:39] Yes. [29:40] As to the quantities of the product sold as to its cost, that is a totally different matter. [29:44] That is correct, Your Honor. [29:45] Even the witness could not testify on that, Your Honor. [29:47] That is correct, Your Honor. [29:48] That is not our intention in presenting this. [29:50] So, the intention is that there is such a product that was applied for registration before the FDA. [29:57] The FDA saw the product. [29:59] The product was submitted. [30:01] It was approved by the FDA and duly registered by the FDA as a product purportedly selling banana chips with a nutritional value at the back of the packaging. [30:13] All the requirements for the registration of the products were duly submitted. [30:18] And after processing, the Food and Drug Administration to the Office of the Gentle Lady approved the certificate of product registration. [30:27] And that KALI 88 complied with the requirements? [30:31] Yes. [30:32] Are they also willing to stipulate? [30:33] I think he just said yes. [30:35] Yes. [30:36] Yes. [30:37] So, just to summarize Your Honor, Attorney Ray, I guess it's best that you summarize. [30:42] I would really summarize Your Honor. [30:43] That if allowed to testify, Your Honor, the witness will attest to the fact that KALI 88 applied for registration. [30:55] In fact, applied for two certificate of product registration. [30:58] One for local manufacture, one for export, and that this application were supported by the appropriate requirements, and they were eventually approved by the Food and Drug Administration, and they were issued the proper certificate of product registration. [31:16] And that KALI 88 complied with the requirements? [31:20] The requirements? [31:21] Yes. [31:22] Okay. [31:23] Okay. [31:25] Your Honor, given the stipulations of the prosecution, we will dispense with a further presentation of the witness, and we just ask that the testimony thus far be admitted, Your Honor. [31:38] For the record, are there any other pictures of the product council? [31:41] Yes, Your Honor. [31:42] Since you don't have, that you have not yet shown? [31:44] Yes, Your Honor. [31:45] Can you show it just for the record? [31:46] May we just request the tech to please show all the photos? [31:51] We refer to Intertech Test Report KALI 88 food. [31:55] Short of a sample, at least show us the pictures of the supposed product applied for registration. [32:05] This is the boxing. [32:06] This is the box. [32:07] Yes, Your Honor. [32:09] Next. [32:11] What other pictures do you have to be identified by the witness? [32:18] This is the actual packaging? [32:20] And the package? [32:21] Of the product, Your Honor. [32:22] According to the witness. [32:23] Yes. [32:24] Can we go back, Ma'am? [32:27] Can you show? [32:28] Can you... [32:30] Tech? [32:31] Caron yung pinapakita mo naman eh. [32:33] Caron, tulungan mo. [32:34] Just unzoom it a bit for larger photos. [32:41] Just the pictures. [32:48] So, I'll specify the documents with the photos, Your Honor. [32:53] Yes, please. [32:54] The first would be KALI 88 food corporation's letter with attached photos of products and packaging data. [32:59] Dated April 30, 2022. [33:00] There you go. [33:01] As testified by the witness. [33:02] Stop, please. [33:03] Yes, these were the ones initially denied. [33:06] Tama po ba? [33:07] Yes, Your Honor. [33:08] Yes, Your Honor. [33:09] Yeah. [33:10] Next are the Intertech test report for KALI 88 food corporation with attached photos of products and packaging dated March 29, 2022, which eventually led to the issuance of the certificate of product registration, Your Honor. [33:26] May ibang pictures pa? [33:33] Yes, Your Honor. [33:34] Pertaining to the second product registration of raw material, these are the photos of generic box for KALI, Your Honor. [33:47] Yes, Your Honor. [33:50] Okay. [33:51] Excuse me. [33:57] Nawala. [33:59] They are part of the second set of documents under FR-976856. [34:05] I think we're satisfied. [34:06] Short of a sample being brought at the appropriate time, should you decide to do so? [34:11] Yes, Your Honor. [34:12] I think the pictures satisfies this court. [34:15] Any senator judge who wish to make interjections? [34:19] If there are none, we will excuse this witness. [34:21] Your Honor, I'm going to conduct a cross. [34:23] Ah, forgive me, Attorney Ray. [34:25] Yes, Your Honor. [34:26] Sorry, I assumed. [34:27] Are you done with your direct, Attorney Justin? [34:29] Yes, Your Honor, given the stipulations. [34:32] Cross, Attorney Ray. [34:33] Yes, Your Honor. [34:34] Yes, a few points, Your Honor. [34:36] Please. [34:38] Ma'am, para lang po magka-idea kami, no? [34:42] Ah, based on our open source research, kayo po ay karir official ng FDA, di po ba? [34:50] 23 years na po yata kayo. [34:53] Actually, in the government service, I'm 36 years already, but in the FDA, started in 2000. [35:00] Okay. [35:01] So... [35:02] 26 years. [35:03] Yeah. [35:04] Okay. [35:05] Salamat po sa servisyo nyo. [35:06] Yes, sa government service. [35:08] Mr. Sand, I have to ask you some questions as part of my job. [35:13] So, kung pwede pong answerable by yes or no, sagutin nyo po ng yes or no. [35:19] Ngayon, kung may kailangan ipaliwanag, I'm sure bibigyan po kayo ng opportunity ng counsel for the respondents. [35:26] Ngayon, kung hindi nyo alam yung sagot or hindi nyo kayang ipaliwanag, pakisabi na lang po para hindi natin i-extend pa po yung discussion. [35:36] So, ang una po po ang tanong, yung pong proseso ng pag-apply ng certificate of product registration, di po ba parang lumalabas na two-stage process po yan? [35:50] Di po ba? [35:51] Kailangan muna meron kang license to operate. Tama po ba? [35:57] Opo, Your Honor, because the license to operate is one of the requirements for product registration. [36:03] So, kailangan muna i-rehistro mo yung factory. [36:08] That's what you called food establishment. [36:11] So, it can be manufacturing. [36:13] Ngayon po. [36:15] So, kaya po napansin ko, ang sinubit yung dokumento, dalawang set po ito, tapos dalawa yung certificate of product registration. [36:28] Isa po yung for export, isa po yung for local. Tama po ba? [36:32] Yes, Your Honor. [36:34] At kasama po dun sa, can we request the tech to project the two certificate of product registration? [36:40] So, ito po yung dalawang certificate of product registration. Medyo maliit po yung sulat, yung ano, no? [36:53] Pero babasahin ko na lang po. Yung una, ito po yung certificate of product registration, [37:02] Calyes Sweetened Banana Chips. [37:05] With FDR registration number, FR-400-900-4164. [37:17] Ito po yata yung para sa local. Tama po ba? [37:20] Yes, Your Honor. [37:21] Kayo po yung nakapirma. Tama po? [37:24] Yes, Your Honor. [37:25] Parang two pages po ito, hindi po ba? [37:28] Yes. [37:30] Ngayon, yung pangalawa, ito po yung certificate of product registration na nakalagay raw material, [37:43] Calyes Sweetened Banana Chips for export market only. [37:47] Ito po yung FR-400-9768-567. Tama po? [37:58] Yes, Your Honor. [37:59] Ang tanong ko po, assuming na merong license to operate yung isang company, no? [38:09] At mag-apply sila ng Certificate of Product Registration for process funds, [38:16] gaano po katagal normally tumatagal yung pag-proseso ng opisina nyo bago mag-issue ng ano? On the average po? [38:25] Yes, Your Honor. [38:27] So, I will… [38:28] Our objective or our target is we have to follow the ease of doing business timeline. [38:35] So, it should be like for us, our target is 20 days. [38:39] 20 days. [38:40] For the Center for Food Regulation and Research, [38:43] the timeline now starts at when the payment was posted. [38:48] And it will be… [38:49] Kasi my payment pa po yung sir, Your Honor. [38:53] So, it will… [38:54] The process kasi is online. [38:56] So, it will not be forwarded to the Center for Food for Evaluation [39:01] if this application has not been… [39:04] The payment has not been posted. [39:06] So, that's the existing… [39:08] Ang tanong ko po, Ma'am, kasi sinasabi nyo payment, [39:12] ibig sabihin that was pre-cleared already. [39:15] Yeah, it was pre-assessed. [39:17] Pero ang normal po is, let's say, bago po akong kumpanya, [39:20] na meron akong license to operate, [39:22] nag-apply po ako ng Certificate of Product Registration. [39:25] On the average, from the time I file my application, [39:28] up to the time ma-issue yung Certificate of Product Registration, [39:32] ano po yung common experience? [39:34] Normally, gano po katagal? [39:35] Gano po katagal, Sir? [39:36] Ah, Your Honor. [39:37] Baka mo ma-process at ma-approve. [39:38] Yeah, we always target on 20 days, [39:41] but because there is an influx of application, [39:45] then we have some backlog. [39:47] Yung po yung tanong ko. [39:48] Gano po katagal on the average? [39:50] On the average, like… [39:51] Considering your backlog? [39:52] Ah, maybe like 30 days maximum. [39:57] 30 days. [39:58] Mga ganon po. [39:59] Anyway, so, ito po yung Certificate of Product Registration. [40:04] Napansin ko po, may inattach din po kayo dito sa parehong, [40:09] parehong set ng documents. [40:13] Meron pong license to operate na inattach kayo. [40:17] Ay, we attach even if it's not submitted by the company [40:22] because what was testified is all the documents that was submitted [40:27] because it's already in the system of FDA, the license to operate. [40:32] So, para lang makita ko. [40:34] So, in effect, can we go to the next slide, please? [40:38] Ito pong license to operate na to, kaya nyo is inattach, [40:42] sinasabi nyo na ito yung license to operate ng kumpanya [40:46] in support of the requirements of the application. Tama po ba? [40:52] Yes, because the license to operate that was attached, that it means na valid, it was renewed. [41:01] Hindi, at tinatanong ko po, ito po ba yung license to operate in support of the application? [41:08] During the time that the CPR was applied, [41:13] ang LTO po nilang na nakalagay doon sa, naka-indicate po sa CPR, [41:20] is yung iba po yung LTO number. [41:23] Nasaan po kaya yun? [41:24] Doon po? [41:25] Nandun sa records namin, sir. [41:27] Bakit po itong inattach nyo eh? [41:29] Iyon yung supposedly yung kasama ng application? [41:32] Eh, sir, kasi expired na siya because the validity ng LTO is until October 9, 2022. [41:40] So, ang tanong ko po, ito po ba o hindi ang LTO na in support of the application? [41:48] Hindi po siya yung LTO. In support ng application during that time, [41:55] the application was filed because the license to operate number there is 855-7334, [42:05] and the expiry date is until October 9, 2022. [42:12] Okay. [42:13] So, the company has filed for the renewal. [42:16] Opo. [42:17] So, ito po kasi, contrary to what you're saying, ang nakalagay po dito, October 9, 2027. [42:25] Thank you. [42:26] Because it was already renewed. [42:27] Before you answer, Ma'am, Marilyn, Attorney Justin? [42:30] Yes, Your Honor. [42:31] We are just objecting, Your Honor, because we're just confused since the prosecution has [42:40] already stipulated that Cali 88 Foods Corporation is already compliant in relation to its application [42:47] for a certificate of food registration. [42:51] No, no, Your Honor. [42:52] And the line of questioning appears to be on the question. [42:57] Secondly, Your Honor, we're pertaining to a renewal, Your Honor. [43:01] So, we do not see. [43:03] It appears to be inconsistent, Your Honor. [43:05] On one hand, they were stipulating. [43:07] Lime to finish. [43:08] On the other hand, they are now questioning the compliance and the assessment made by [43:15] the FDA. [43:16] Your Honor, what we stipulated on is that they submitted the requirements and the CPR was [43:23] issued in the course. [43:24] We request a back read, Your Honor. [43:25] Now, Your Honor, what we are asking the witness is regarding the supporting documents. [43:30] We would just like to know if the proper supporting documents were submitted because, as the witness [43:37] must exist, before a CPR is issued, a valid license to operate must exist. [43:43] No? [43:44] And we are looking at this license to operate, Your Honor, and it does not have a date of issuance. [43:51] Your Honor. [43:52] So, can we just be allowed to ask the witness regarding this so that she can explain? [43:58] If she can, Your Honor. [43:59] Just then I'll allow it and then move to your next point, Attorney Ray. [44:02] Yes, Your Honor. [44:03] Yes, Your Honor. [44:04] But given the statement of Attorney Ray, of the extent of his stipulation, we request [44:09] a back read of the transcript right now to confront him with the exact stipulations [44:14] he made. [44:15] Because otherwise, if that is his position, we have been misled in giving up our direct [44:20] examination and we'll ask that we be allowed to reconduct the same, Your Honor. [44:24] This is all fairness, Your Honor. [44:25] We ask a back read of the transcript of stenographic notes and the exact wording that were uttered [44:31] from the mouth of Attorney Ray, just for fairness, Your Honor. [44:35] Attorney Ray, you stipulated that CALE 88 complied with all the requirements of the FDA and that [44:47] the permits and licenses were duly issued in accordance with law. [44:51] Your Honor, I remember my exact word, submitted all of the requirements and they were issued. [44:57] So now you're questioning what? [44:59] No, Your Honor, I'm just trying to clarify from the witness because the document does not [45:05] state when the LTO was issued. [45:07] And if you get a date or not a date, so? [45:11] Then we can, the court would be informed if the requirements were properly complied with. [45:18] Your Honor, we ask a back read of the DSM. [45:21] Precisely, precisely, counsel. [45:23] You stipulated that... [45:25] They submitted the requirements and the CPR was issued. [45:29] We request a back read, Your Honor. [45:31] In due course. [45:32] In due course. [45:33] Yes, Your Honor. [45:34] That they complied. [45:35] I think Attorney Justin asked for it that they complied with the requirements of the FDA [45:41] and that therefore the license was issued in due course. [45:44] Well, we're just trying to clarify this particular document, Your Honor. [45:48] This is my only other point, Your Honor. [45:50] After this, I'll move on, Your Honor. [45:52] I'd rather that you move on, counsel. [45:56] Okay. [45:57] Move on to your next point. [45:58] Ngayon, ang isa pong, Ma'am Pilar, ang isa pong punto na sinasabi po ng prosecution [46:08] kaya kayo pinresenta, kasi daw po, kayo ay tetestigo na ang Calde 88 Food Corporation [46:16] ay engaged sa lawful legitimate export business of sweetened banana chips. [46:23] Ang tanong ko po, after po ma-issue itong certificate of product registration, [46:31] minonitor niyo po ba yung negosyo ng Calde 88? [46:36] Your Honor, that's not part of our job. [46:38] Opo. [46:39] Because yun po, safety, quality yung aming proseso sa pag-evaluate po ng application. [46:47] So, hindi niyo po matestatestiguhan na lawful, legitimate ang negosyo ng Calde 88 [46:56] at hindi niyo rin po mapapasinungalingan yun, di po ba? [46:59] Kasi hindi niyo naman binantayan ang operations nila. [47:02] Tama po? [47:05] Kindly answer through the mic, Ma'am. [47:07] Don't just shake your head. [47:08] Tama po. [47:09] Hindi. [47:10] Ulitin ko po, Your Honor, na hindi po kasama yun sa trabaho namin. [47:15] So, hindi po ako makasag. [47:17] Okay lang. [47:19] Start ng job. [47:20] Your Honor, I am just asking the witness. [47:23] Because the purpose said that she will testify that the Calde 88 is engaged in lawful export. [47:31] I'm trying to clarify if she can. [47:33] Now, the other, hindi niyo rin po masasabi, kung totoong nagmanufacture ng banana chips for export ang Calde 88. [47:46] Your Honor, apology. [47:47] We are now really confused, Your Honor. [47:49] And it is at this point that we will respectfully insist a back-read and production of the transcript of stenographic notes [47:56] because the direction of Attorney Ray's cross-examination is diametrically opposed to his previous stipulations, Your Honor. [48:05] This is the only other point, Your Honor. [48:06] We have to be able to be clarified of the extent of the stipulations. [48:10] This has nothing to do with the certificate of fraud registration. [48:14] This is not a debate. [48:15] Kindly allow Attorney Justin to finish and then I'll allow you to comment. [48:18] We are just asking, Your Honor, that the extent and the words uttered by Attorney Ray be produced [48:24] through a back-read of stenographic notes, which I'm sure Attorney Ray understands is normal in court proceedings [48:31] and in courts of record for us to exactly know the extent of the stipulations and his response to our request of clarification. [48:39] The reason being, Your Honor, is because we withdrew our direct examination precisely [48:44] of the extent of the stipulations. [48:49] Otherwise, we already expressed our intent to continue with our direct examination, Your Honor. [48:56] Your Honor, I believe... [48:57] Our objection right now, and I hope Attorney Ray would allow me to finish, [49:00] is that that track of his cross-examination is diametrically opposed to the previous stipulations he already made. [49:08] Can I be allowed now, Your Honor, to say my piece? [49:11] Are you sorry, Your Honor? [49:12] We just asked that the records clarify. [49:14] My questions now have nothing to do with the stipulation. [49:19] I am asking the witness, after the issue once of the certificate of fraud registration, [49:25] did she keep track of the business? [49:27] Your Honor, I think that's even part of the stipulations that... [49:29] That's not, Your Honor. [49:30] The extent of production, which was offered by the presiding officer, the tonnage, [49:35] is outside the competence of the witness, Your Honor. [49:38] I would have to sustain the objection. [49:42] Forgive me, Attorney Justin, short of a back read. [49:44] I'm still getting a copy of the TSN. [49:46] Apologies, sir. [49:47] I would have to sustain the objection, Attorney Ray, [49:49] on the ground that it has already been asked and answered specifically by the presiding officer [49:55] that the witness would not be qualified to testify as to whether or not these were actually manufactured [50:02] and or sold and as to the quantities produced and or quantities sold, locally or internationally. [50:08] So the witness will not be able to answer that, sir? [50:11] Yes, the witness will not be able to answer that, sir. [50:11] Without, Your Honor, I'm ending my cross. [50:14] Thank you. [50:15] And I redirect, Attorney Justin. [50:17] None, Your Honor, but we just request the appropriate time for the back read. [50:22] As soon as I get it, as soon as I get the complete set. [50:25] We will do that before we direct examination. [50:28] If there are no interjections, Senator Judge Amy, none. [50:38] Senator Judge Amy is recognized. [50:39] You may proceed when you're ready, ma'am. [50:40] You have two minutes. [50:41] Yes, maraming salamat. [50:43] Para umabot tayo ng pitong oras tungkol sa banana, Chief's presiding officer po. [50:48] Does the FDA ordinarily evaluate the manufacturing facilities, equipment, sanitation standards, [50:54] quality control of an applicant seeking a manufacturer's license? [50:58] Kasi sinabi ninyo kanina, nag-e-evaluate talaga kayo bago mag-rehistro. [51:04] Yes, Your Honor, but I was asked to appear for the product registration. [51:10] I mean, I mean... [51:11] Yes, but that's part and parcel of the FDA's due diligence, ika nga, bago magbigay ng registry, di ba? [51:20] Yes, Your Honor. [51:21] Tapos, in Kale 88's case, what evaluation or inspection did you undertake before issuing its license to operate? [51:31] The license, Your Honor, the license to operate is there are other offices in the FDA. [51:36] It's not only the Center for Food Regulation and Research. [51:39] The one handling the inspection is the Field Regulatory Operations Office. [51:45] But to the best of your knowledge, pumasa naman to sa FDA evaluation and inspection. [51:51] Precisely because there's an issuance of the LTO. [51:55] That's right. [51:56] Oo, so you were able to act on it rapidly upon approval of the inspecting group. [52:03] Yes. [52:03] And based on the FDA records, did Kale 88 identify a manufacturing facility where its products would be produced, in fact? [52:13] Nag-identify sila ng address at lugar. [52:17] Yes, Your Honor, but I didn't bring the document. [52:22] Yes, that's right. [52:23] Pero, at least na kasi yun sa trabaho ninyo. [52:25] Pero, meron namang ganun. [52:27] Opo. [52:27] So, klaro kung saan sila mag-produce, ng banana chips na mahiwaga at iba pa. [52:32] Okay, maraming salamat yun lang po. [52:35] Thank you po, Your Honor. [52:36] Thank you, Senator Judge Amy. [52:39] There will be another Senator Judge who registered to make interjections. [52:49] The Chair, excuses. [52:53] Ms. Marilyn. [52:54] Thank you. [52:55] Ms. Marilyn, maraming salamat po sa inyong oras, panahon at pagsagot sa katanungan. [52:59] Maswerte po kayo at maikli lang kayo. [53:01] Thank you din po. [53:02] Salamat po. [53:04] I will do the back read as soon as I get it, Attorney Justin. [53:06] Your Honor, before the next week, this is called. [53:08] May I just ask that the lead defense counsel be recognized. [53:12] May I just excuse the witness first? [53:14] Yes, Your Honor. [53:14] Salamat po. [53:15] Gayun din sa pagsagot sa tanong ng Senator Judge. [53:20] Kaugnay ng paglilitis na ito. [53:22] Your excuse, ma'am. [53:23] Thank you, Your Honor. [53:25] Thank you, all. [53:25] Thank you, ma'am. [53:26] Thank you po. [53:26] For the record, in response to the request of Attorney Justin, [53:41] Mr. Robles, I already summarized Your Honor. [53:48] If allowed to testify, Your Honor, the witness will attest to the fact that Cali 88 applied for registration. [53:54] In fact, applied for two certificates of registration, one for local manufacturer, one for export, [54:01] and that the application was supported by the appropriate requirements, [54:04] and they were eventually approved by the Food and Drug Administration, [54:08] and they were issued the proper certificate of product registration. [54:12] Attorney, Mr. Goulart. [54:14] And that Cali 88 complied with the requirements. [54:16] Mr. Robles, the requirements. [54:18] Yes. [54:23] And then we proceed with the presiding officer asking that the pictures be shown. [54:32] Yung bago nun, non-manufacturing yun, nang wala pa ako. [54:34] Thank you, Your Honor. [54:36] That is all that we ask, Your Honor. [54:38] Thank you. [54:39] And we thank the court. [54:40] Thank you. [54:41] Your next witness, counsel, or Attorney Sheila? [54:44] Before we call the next witness, we just ask that the lead... [54:46] Yes, Attorney Sheila, what is your pleasure, ma'am? [54:51] Thank you. Good afternoon, Your Honors. [54:54] Before the court calls, our next witness, [54:57] Ms. Rowena Mendoza, the representative... [55:02] It will be Attorney Marikina already. [55:04] Yes, in view of Ms. Mendoza from CITEM. [55:07] We'd like to inform the court that we will be dispensing [55:09] with the presentation of this witness, [55:11] considering also the lateness of the hour, [55:14] and in the interest of time. [55:17] And having heard what the court and the senators' judges [55:23] have expressed earlier on the information [55:27] that they would rather see and hear from the witnesses of the defense, [55:31] we will be presenting other witnesses [55:33] when the hearings resume after the break. [55:38] Okay. [55:39] So we have no more witness for today? [55:41] Yes, Your Honor. [55:42] The witness from the FDA is our last witness for today. [55:46] You won't hear any objection from me for sure, [55:49] or anyone from us, Attorney Sheila. [55:53] Thank you. [55:53] Before we call it a day, [55:58] I was informed... [55:58] I'd like to inform the body of the succeeding hearings, rather. [56:08] Given the adjustments that are being made [56:11] in connection with the budget, [56:14] subject to notice being given a day before, [56:18] if we will cancel. [56:19] Again, because the budget deliberations are a moving target, [56:23] and as you know, [56:24] it is one of the most important pieces of legislation we should pass, [56:29] but nevertheless, we are multitasking, [56:31] and upon prior consultation with the Senate President, [56:35] this will be our schedule for the next couple of weeks, [56:40] hopefully until we adjourn. [56:43] Again, unless notified a day before [56:45] that we will be cancelling it to give way to the budget, [56:48] and unless we notify the parties a day before [56:52] if we will be conducting a whole-day hearing, [56:55] we will revert to the original schedule of 10 to 3 p.m. [57:02] And our next scheduled date will be November 26, 27, [57:12] and then 1, 2, 3, 4, 7, 8, 9, 10, 11, [57:20] and until we adjourn on the 18th, [57:23] depending on whether or not we still need it, [57:25] depending on how the trial will progress, [57:29] meaning to say when the defendant will rest, [57:34] if there will be any rebuttal evidence, [57:36] if there will be any rebuttal evidence, [57:38] and time to be given for the formal offer, [57:42] comment there to, [57:43] and ruling of the impeachment court. [57:46] So to repeat, we revert to the original schedule [57:51] of 10 a.m. to 3 p.m. [57:55] We will adjourn, and our next trial date [57:57] will be on November 26 and 27, [58:01] the following week, December 1, 2, 3, 4, [58:06] because November 30 is a holiday, [58:09] December 7, 8, 9, 10, 11, 14, 15, 16, 17, [58:13] as may be necessary. [58:15] Again, without prejudice to notice being given a day before, [58:18] if we will cancel the trial to give way to the budget, [58:21] and if we will have a whole day session, [58:24] otherwise it will only be from 10 to 3, [58:27] or 10 to 2, as the case may be, [58:30] because we still have to rearrange the plenary [58:34] for the information and guidance [58:36] of the parties concerned. [58:42] December 2 is Pasay Day, [58:45] but we usually do not follow the local holiday, [58:53] but we follow the November 30 holiday, [58:55] so there will be no trial nor session on November 30. [58:59] Your Honor. [58:59] Yes, comment. [59:01] Attorney Sheila? [59:02] Yes, Your Honor. [59:03] We would like to be candid to the court [59:05] and say that our next witnesses [59:08] are not available on 26 and 27. [59:12] Also, given that we were only informed today [59:16] that there will be hearings for next week, [59:21] and as you know, Your Honor, [59:22] this is not our only commitment, [59:25] so we have also already made some commitments [59:29] in our other engagements, [59:33] but nonetheless, we assure this court [59:36] that we will not, [59:37] and in fact, we are not interested [59:39] in a protracted, prolonged trial of this case. [59:42] And as this court had seen, [59:46] the defense has been prudent [59:47] with the time of this court, [59:50] has not abused this court, [59:51] and has not wasted three months of time [59:55] for presenting witnesses [59:56] that will eventually be withdrawn, Your Honor. [59:59] Move to strike, Your Honor. [1:00:01] Move to strike. [1:00:02] I'm stating a fact, Your Honor. [1:00:03] Allow... [1:00:04] No, no, no. [1:00:04] It's a fact, Your Honor. [1:00:06] Allow her to finish first. [1:00:07] Wasting three months is a conclusion, Your Honor. [1:00:10] Move to strike. [1:00:11] Well, it is not a conclusion. [1:00:13] It is a fact. [1:00:14] It's part of the record. [1:00:15] No, it was not wasted, Your Honor. [1:00:17] I think that needs to be clear. [1:00:18] Honorable Redondi, it's not a debate. [1:00:20] Let Attorney Sheila finish, [1:00:22] and the court will make the corresponding opportunity, [1:00:24] give you the corresponding opportunity, [1:00:25] and make the corresponding ruling as well. [1:00:27] Yes, Your Honor. [1:00:27] Well, if the Congressman Redondi would like again a readback [1:00:34] of the day when they withdrew the witnesses, [1:00:38] would he prefer that I'm stating a fact? [1:00:41] It was a factual statement. [1:00:43] At any rate, to continue, [1:00:44] our witnesses are not available on the 26th and 27th, [1:00:48] but we are ready to resume on December 1, 2, 3, 2, [1:00:53] and 4, and we heard also this court say [1:01:00] that it's reserving a hearing date on 14th. [1:01:03] As may be necessary, Councilor. [1:01:04] As may be necessary, 16th 17th. [1:01:06] I think we will make sure that we will not, again, [1:01:14] abuse the time of this court [1:01:15] and finish the presentation of defense [1:01:18] even prior to the additional date set by this court, Your Honor. [1:01:22] But on the 26th and 27th, [1:01:24] we ask for the indulgence of this court [1:01:26] to allow us to just cancel. [1:01:29] Anyway, as per the pre-trial order, [1:01:32] we ask for 30 days for the presentation of our witnesses, [1:01:37] and the court can just deduct these two days [1:01:40] from our time, Your Honor. [1:01:41] Thank you. [1:01:43] Just to note, Council, [1:01:44] the 30 days is for four articles, [1:01:46] but just to clarify, [1:01:48] the 30 days was for the four articles. [1:01:50] I understand, Your Honor. [1:01:51] So we canceled the 26th and the 27th [1:01:56] given the fact that Council for Respondent [1:01:58] and their witnesses are not, [1:02:00] might not be, [1:02:02] might not, [1:02:02] are you already sure, Attorney Shila? [1:02:04] Yes, Your Honor. [1:02:05] Are not available. [1:02:06] Yes, Your Honor. [1:02:07] We were informed that they're not available [1:02:10] on the 26th and 27th, Your Honor. [1:02:12] Okay. [1:02:13] So we shall resume hearing [1:02:15] where your witness will be available [1:02:16] on December 1. [1:02:18] Yes, Your Honor. [1:02:19] And we shall have four trial dates in that week. [1:02:24] One, two, three, and four. [1:02:26] Yes, Your Honor. [1:02:27] And as may be necessary, [1:02:28] five trial dates on the following week. [1:02:31] Yes, Your Honor. [1:02:32] Would that be correct? [1:02:32] Yes, Your Honor. [1:02:34] One, two, three, and four, [1:02:35] but I just heard the presiding officer [1:02:37] state earlier that it would be adding [1:02:40] 14th, 16th, and 17th. [1:02:42] If necessary, if necessary. [1:02:43] If necessary, Your Honor. [1:02:45] That may be for the court already, [1:02:47] actually, Attorney Shila. [1:02:49] Yes, Your Honor. [1:02:50] At this point, [1:02:51] we assure this court and the public [1:02:53] we will not be wasting any time. [1:02:55] And I also make known [1:02:57] before this court [1:02:59] what I stated in an interview [1:03:01] that it is my hope [1:03:02] that we can decide [1:03:05] one way or the other [1:03:06] on this matter, [1:03:08] on this case, [1:03:08] before we adjourn as a Congress [1:03:11] and before the year is over. [1:03:14] Again, one way or the other [1:03:15] so that both as a country and a people, [1:03:19] we can move forward accordingly, [1:03:21] whatever the outcome of this trial may be, [1:03:23] without impinging on, of course, [1:03:26] the rights of the respondent. [1:03:27] That's why we are allocating enough time [1:03:29] for the respondent [1:03:31] as well as the prosecution. [1:03:32] If ever, they will still go [1:03:33] to the process of rebuttal [1:03:35] or surrebuttal evidence [1:03:37] as the case may be. [1:03:39] We understand that. [1:03:40] On the motion earlier made [1:03:42] by the Honorable Redon, [1:03:47] with your indulgence, Attorney Shila, [1:03:49] let's just replace it [1:03:50] with spent a lot of time [1:03:52] in lieu of the word waste [1:03:54] in the course of the past months. [1:04:00] Your Honor. [1:04:01] I'm fine with that, Your Honor. [1:04:02] Thank you. [1:04:03] Your Honor. [1:04:05] I'm sorry. [1:04:05] December 8th is also a holiday, [1:04:07] I was told just now. [1:04:08] So that is the bill [1:04:11] of our former Senate President, [1:04:13] Senator Judge, [1:04:15] former Senate President Soto. [1:04:17] Your Honor. [1:04:18] Yes, Honorable Redon. [1:04:19] I think it needs to be stated [1:04:21] that the defense [1:04:22] has already canceled the day previously [1:04:24] and they will cancel two more days. [1:04:28] So I think a consequence [1:04:29] needs to be placed on the defense, [1:04:31] particularly [1:04:31] lessening the days of presentation [1:04:35] that they have. [1:04:36] And as stated by the presiding officer, [1:04:38] the 30 days that they're mentioning [1:04:40] relates to four articles of impeachment. [1:04:43] So I think it needs to be settled [1:04:45] at this point. [1:04:46] What exactly are the specific number of days [1:04:49] that they have to basically present [1:04:51] their defense on unexplained wealth? [1:04:54] I think Attorney Sheila already answered [1:04:56] that in the previous hearing, [1:04:57] Counsel, if I'm not mistaken, [1:05:00] she gave a number of 8 to 10. [1:05:02] And I think, [1:05:03] That's correct. [1:05:03] Barring any unforeseen, [1:05:06] the dates on from the 1st to the 4th [1:05:09] might be enough [1:05:10] depending on how long [1:05:11] the cross and the direct will be. [1:05:15] And if you're looking [1:05:16] at a tentative timeline [1:05:17] for the information again [1:05:18] of the parties, [1:05:20] if that is finished [1:05:22] on the week of the 4th, [1:05:24] ending in the 4th, [1:05:25] then the following week [1:05:26] will be for offer [1:05:27] and the following week [1:05:29] would be for preparation [1:05:31] by the senator judges [1:05:33] and or arguments of the parties [1:05:35] before the court schedules [1:05:39] a vote on the matter. [1:05:41] If, again, [1:05:43] there are no unforeseen circumstances [1:05:45] such as rebuttals or rebuttal [1:05:47] and similar procedures [1:05:48] that are part of the rules of court. [1:05:50] As a final point, Your Honor, [1:05:52] they mentioned that they wanted [1:05:53] to cancel the next two hearing dates [1:05:56] and that presumes [1:05:57] that they have information already [1:05:59] as to who the witnesses will be [1:06:02] who are basically unavailable [1:06:04] for the next two hearing dates. [1:06:07] Is it possible at this point [1:06:08] for us to actually know [1:06:10] who these specific witnesses are [1:06:13] and how many actually [1:06:15] are remaining witnesses [1:06:16] for the defense at this point? [1:06:18] Comment, Attorney Sheila? [1:06:19] Yes, Your Honor. [1:06:21] But before I respond [1:06:23] to that last question, [1:06:24] let me, if the court [1:06:25] will allow me to respond [1:06:27] to the 30-day comment [1:06:31] or statement. [1:06:32] Allow me, Attorney Sheila, [1:06:33] so as not to belabor the point. [1:06:36] The court simply notes [1:06:37] the manifestation [1:06:39] of the Honorable Redon [1:06:40] on the dates [1:06:41] and on the canceled trial dates. [1:06:45] It will take it in advisement [1:06:46] and will not take it [1:06:47] against any party [1:06:49] as this has been done [1:06:51] also in the past [1:06:52] by the prosecution [1:06:54] and will not take it [1:06:55] against the respondent [1:06:57] at this point in time. [1:06:58] Your Honor, thank you. [1:06:59] All I'm going to say [1:07:00] is that I think [1:07:03] for purposes of this [1:07:06] entire trial [1:07:07] and before this Honorable Court, [1:07:11] both the prosecution [1:07:12] and defense [1:07:12] stand on equal footing. [1:07:14] And so if under the law [1:07:16] and under the rules [1:07:17] the prosecution [1:07:17] retains the prerogative [1:07:19] to direct [1:07:20] the way [1:07:22] that they will go [1:07:24] with their presentation, [1:07:25] then the same prerogative [1:07:27] should be allowed [1:07:28] the defense. [1:07:30] And if [1:07:31] we find it [1:07:33] sufficient [1:07:34] to just allot [1:07:35] one day [1:07:37] for an article [1:07:38] before the three other articles [1:07:40] where we're drawn [1:07:41] by the prosecution, [1:07:41] then that is [1:07:43] our prerogative. [1:07:44] So I don't see [1:07:45] how that 30-day comment [1:07:47] matters here. [1:07:48] But at any rate, [1:07:48] Your Honor, [1:07:49] with respect to the disclosure [1:07:51] of the witnesses, [1:07:51] yes, [1:07:52] but we will comply [1:07:54] with the five-day period [1:07:55] before we disclose [1:07:57] the witnesses [1:07:58] that we will present [1:07:59] starting December 1, [1:08:01] Your Honor. [1:08:02] This is also consistent [1:08:03] with what the prosecution [1:08:04] had done [1:08:05] and had extended [1:08:06] to the defense [1:08:07] in the past [1:08:07] during their time [1:08:09] of presentation. [1:08:10] Attorney Sheila, [1:08:10] to save on [1:08:13] the court's time [1:08:13] as well, [1:08:14] can you submit [1:08:14] for December 1 [1:08:16] and sequentially [1:08:18] at least two, [1:08:19] depending on how long [1:08:20] you think it will take, [1:08:21] but at least two witnesses [1:08:22] for sure. [1:08:23] So that should we finish [1:08:24] with one witness, [1:08:25] we can proceed [1:08:25] with the next, [1:08:27] as long as you comply [1:08:28] with the five-day [1:08:29] notice rule [1:08:30] sequentially [1:08:30] for the December 1, [1:08:32] 2, 3, and 4 hearings. [1:08:33] In fact, [1:08:33] Your Honor, [1:08:34] we plan to submit [1:08:35] before December 1 [1:08:38] the witnesses [1:08:38] that we will be presenting [1:08:40] for the week of December 1 [1:08:41] to 4. [1:08:42] So that would be [1:08:42] more than enough, [1:08:44] more than five days. [1:08:45] That's more than five days. [1:08:46] Yes. [1:08:46] Your Honor. [1:08:47] Is that satisfactory, [1:08:49] Honorable Dutan? [1:08:50] We submit, Your Honor. [1:08:51] Thank you. [1:08:52] Any other matters [1:08:53] you want to take up? [1:08:55] There being no other matters [1:08:56] to be taken up [1:08:57] and given the manifestation [1:08:58] of the lead counsel [1:09:01] for the respondent [1:09:02] that the witnesses [1:09:04] are not available [1:09:05] on November 26 and 27. [1:09:08] and given the commitment [1:09:13] of the counsel [1:09:15] for the lead counsel [1:09:17] for the respondent [1:09:18] that in compliance [1:09:20] with the five-day notice rule [1:09:22] and even more than that, [1:09:23] in fact, [1:09:24] they will submit [1:09:24] their list of witnesses [1:09:27] for the coming week [1:09:29] of December 1 to 4 [1:09:30] to afford the opportunity [1:09:33] to the prosecution [1:09:34] on the other side [1:09:34] to prepare [1:09:35] for these witnesses [1:09:36] as well. [1:09:37] And as the rule suggests too, [1:09:41] any subpoena document [1:09:42] submitted to the court [1:09:43] will automatically [1:09:44] be reproduced by the court [1:09:46] and furnish the parties. [1:09:47] Would that be okay? [1:09:49] Yes, Your Honor. [1:09:50] Also, Your Honor, [1:09:51] just one more matter. [1:09:52] I forgot. [1:09:53] We will also be asking [1:09:54] for a schedule [1:09:55] of the marking [1:09:55] of the documents [1:09:56] that were requested [1:09:58] to be marked [1:09:59] since yesterday. [1:10:00] When do you want that done, [1:10:01] Counsel? [1:10:02] Of course, [1:10:03] we will also ask [1:10:03] the availability of the process. [1:10:04] Kindly just agree [1:10:05] with the clerk of court? [1:10:06] Yes, Your Honor. [1:10:07] Thank you. [1:10:09] Next week. [1:10:09] Anytime next week. [1:10:10] I think we will have time. [1:10:12] Thank you, Your Honor. [1:10:13] Okay. [1:10:14] There being no other matters [1:10:15] to be taken up, [1:10:16] trial is adjourned [1:10:17] until December 1, [1:10:21] 2026. [1:10:23] That's a Tuesday [1:10:24] at 10 o'clock [1:10:25] in the morning. [1:10:26] Thank you.

Transcribe Any Video or Podcast — Free

Paste a URL and get a full AI-powered transcript in minutes. Try ScribeHawk →